Tryptamine Therapeutics(AU:ENP)
A$0.030.00 (0.00%)
AU:ENP
Tryptamine Therapeutics financials statements
A$0.03
At close:0.00 (0.00%)
Want to see AU:ENP full AI Analyst Report?
Tryptamine Therapeutics (ENP) Income Statement
19 Followers
Tryptamine Therapeutics Income Statement
Last quarter (Q4 2025), Tryptamine Therapeutics's total revenue was AU$0.00. In Q4, Tryptamine Therapeutics's net income was AU$-1.44M. See Tryptamine Therapeutics’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Jun 26 | Aug 24 | Jun 23 | Jun 22 | Jun 21 |
|---|---|---|---|---|---|
| AU$ 0.00 | AU$ 0.00 | AU$ 0.00 | AU$ 618.57K | AU$ 99.73K | |
| AU$ -27.34K | AU$ -54.34K | AU$ -6.77K | AU$ 618.57K | AU$ 99.73K | |
| AU$ 6.74M | AU$ 6.68M | AU$ 4.96M | AU$ 10.21M | AU$ 14.21M | |
| Depreciation and Amortization | AU$ 27.34K | AU$ 54.34K | AU$ 6.77K | AU$ 1.70M | AU$ 1.73M |
| AU$ -6.74M | AU$ -5.27M | AU$ -6.70M | AU$ -5.10M | AU$ -8.27M | |
| AU$ -6.77M | AU$ -6.73M | AU$ -4.97M | AU$ -9.59M | AU$ -14.11M | |
| AU$ -8.17K | AU$ -184.29K | AU$ -2.28M | AU$ 2.46M | AU$ 4.03M | |
| AU$ -6.78M | AU$ -6.91M | AU$ -7.25M | AU$ -7.13M | AU$ -10.08M | |
| AU$ -4.87M | AU$ -5.33M | AU$ -6.14M | AU$ -7.13M | AU$ -10.08M | |
| Per Share Metrics | |||||
| Basic EPS | AU$ -0.00 | AU$ -0.00 | AU$ -0.01 | AU$ -0.09 | AU$ -0.14 |
| Diluted EPS | AU$ -0.00 | AU$ -0.00 | AU$ -0.01 | AU$ -0.09 | AU$ -0.14 |
| Weighted Average Shares Outstanding | 1.57B | 1.38B | 506.71M | 78.76M | 71.08M |
| Weighted Average Shares Outstanding (Diluted) | 1.57B | 1.38B | 506.71M | 78.76M | 71.08M |
Currency in AUD
